Literature DB >> 21304000

Markers of pancreatic cancer: working toward early detection.

Michael Goggins1.   

Abstract

Because early detection of pancreatic cancer is the best way to cure this disease, investigators continue to try to identify accurate markers of early pancreatic cancer. Because early-stage pancreatic cancer is generally asymptomatic, the only reliable way to detect it is by targeting individuals at increased risk for pancreatic screening. ©2011 AACR.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21304000      PMCID： PMC3079322          DOI： 10.1158/1078-0432.CCR-10-3074

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  11 in total

1.  Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer.

Authors:  T A Brentnall; M P Bronner; D R Byrd; R C Haggitt; M B Kimmey
Journal:  Ann Intern Med       Date:  1999-08-17       Impact factor: 25.391

2.  Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

Authors:  Marcia Irene Canto; Michael Goggins; Ralph H Hruban; Gloria M Petersen; Francis M Giardiello; Charles Yeo; Elliott K Fishman; Kieran Brune; Jennifer Axilbund; Constance Griffin; Syed Ali; Jeffrey Richman; Sanjay Jagannath; Sergey V Kantsevoy; Anthony N Kalloo
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-06       Impact factor: 11.382

3.  DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.

Authors:  Hiroyuki Matsubayashi; Marcia Canto; Norihiro Sato; Alison Klein; Tadayoshi Abe; Keishi Yamashita; Charles J Yeo; Anthony Kalloo; Ralph Hruban; Michael Goggins
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

4.  Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels.

Authors:  Ang Li; Noriyuki Omura; Seung-Mo Hong; Audrey Vincent; Kimberly Walter; Margaret Griffith; Michael Borges; Michael Goggins
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

5.  Serum biomarker panels for the detection of pancreatic cancer.

Authors:  Randall E Brand; Brian M Nolen; Herbert J Zeh; Peter J Allen; Mohamad A Eloubeidi; Michael Goldberg; Eric Elton; Juan P Arnoletti; John D Christein; Selwyn M Vickers; Christopher J Langmead; Douglas P Landsittel; David C Whitcomb; William E Grizzle; Anna E Lokshin
Journal:  Clin Cancer Res       Date:  2011-02-15       Impact factor: 12.531

Review 6.  An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Authors:  Ralph H Hruban; Kyoichi Takaori; David S Klimstra; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Sandra A Biankin; Carolyn Compton; Noriyoshi Fukushima; Toru Furukawa; Michael Goggins; Yo Kato; Gunter Klöppel; Daniel S Longnecker; Jutta Lüttges; Anirban Maitra; G Johan A Offerhaus; Michio Shimizu; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

7.  Circulating mutant DNA to assess tumor dynamics.

Authors:  Frank Diehl; Kerstin Schmidt; Michael A Choti; Katharine Romans; Steven Goodman; Meng Li; Katherine Thornton; Nishant Agrawal; Lori Sokoll; Steve A Szabo; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Nat Med       Date:  2007-07-31       Impact factor: 53.440

8.  The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Authors:  J W Poley; I Kluijt; D J Gouma; F Harinck; A Wagner; C Aalfs; C H J van Eijck; A Cats; E J Kuipers; Y Nio; P Fockens; M J Bruno
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

9.  The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays.

Authors:  Tingting Yue; Irwin J Goldstein; Michael A Hollingsworth; Karen Kaul; Randall E Brand; Brian B Haab
Journal:  Mol Cell Proteomics       Date:  2009-04-17       Impact factor: 5.911

10.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962
View more
  22 in total

Review 1.  Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.

Authors:  Cristiana Pistol Tanase; Ana Iulia Neagu; Laura Georgiana Necula; Cristina Mambet; Ana-Maria Enciu; Bogdan Calenic; Maria Linda Cruceru; Radu Albulescu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.

Authors:  Zobeida Cruz-Monserrate; Wael R Abd-Elgaliel; Tobias Grote; Defeng Deng; Baoan Ji; Thiruvengadam Arumugam; Huamin Wang; Ching-Hsuan Tung; Craig D Logsdon
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

3.  Role of IL-6 in the resolution of pancreatitis in obese mice.

Authors:  Maria Pini; Davina H Rhodes; Karla J Castellanos; Andrew R Hall; Robert J Cabay; Rohini Chennuri; Eileen F Grady; Giamila Fantuzzi
Journal:  J Leukoc Biol       Date:  2012-03-16       Impact factor: 4.962

Review 4.  Nuclear receptors and pathogenesis of pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 5.  Strategies for discovering novel pancreatic cancer biomarkers.

Authors:  Alison Chan; Eleftherios P Diamandis; Ivan M Blasutig
Journal:  J Proteomics       Date:  2012-09-28       Impact factor: 4.044

6.  MicroRNA alterations of pancreatic intraepithelial neoplasias.

Authors:  Jun Yu; Ang Li; Seung-Mo Hong; Ralph H Hruban; Michael Goggins
Journal:  Clin Cancer Res       Date:  2011-11-23       Impact factor: 12.531

7.  Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening.

Authors:  Chin Hur; Angela C Tramontano; Emily C Dowling; Gabriel A Brooks; Alvin Jeon; William R Brugge; G Scott Gazelle; Chung Yin Kong; Pari V Pandharipande
Journal:  Pancreas       Date:  2016-08       Impact factor: 3.327

8.  Microchip immunoaffinity electrophoresis of antibody-thymidine kinase 1 complex.

Authors:  Jayson V Pagaduan; Madison Ramsden; Kim O'Neill; Adam T Woolley
Journal:  Electrophoresis       Date:  2015-02-03       Impact factor: 3.535

9.  Pancreatic ductal adenocarcinoma screening: new perspectives.

Authors:  Raffaele Pezzilli; Dario Fabbri; Andrea Imbrogno
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

10.  Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia.

Authors:  Mitsuro Kanda; Yoshihiko Sadakari; Michael Borges; Mark Topazian; James Farrell; Sapna Syngal; Jeffrey Lee; Ihab Kamel; Anne Marie Lennon; Spencer Knight; Sho Fujiwara; Ralph H Hruban; Marcia Irene Canto; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-28       Impact factor: 11.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.